Abstract:Pharmaceutical evaluations of nanomedicines are of great significance for their further launch into industry and clinic. Near-infrared (NIR) fluorescence imaging plays essential roles in preclinical drug development by providing important insights into the biodistributions of drugs in vivo with deep tissue penetration and high spatiotemporal resolution. However, NIR-II fluorescence imaging has rarely been exploited for in vivo real-time pharmaceutical evaluations of nanomedicine. Herein, we developed a highly emissive NIR-II luminophore to establish a versatile nanoplatform to noninvasively monitor the in vivo metabolism of nanomedicines bound various polyethylene glycol (PEG) ligands in a real-time manner. An alternative D–A–D conjugated oligomer (DTTB) was synthesized to achieve NIR-II emission peaked at ∼1050 nm with high fluorescence QYs of 13.4% and a large absorption coefficient. By anchoring with the DTTB molecule, intrinsically fluorescent micelles were fabricated and bound with PEG ligands at various chain lengths. In vivo NIR-II fluorescence and photoacoustic imaging results revealed that an appropriate PEG chain length could effectively contribute to the longer blood circulation and better tumor targeting. In vivo therapeutic experiments also confirmed the optimized nanomedicines have efficient photothermal elimination of tumors and good biosafety. This work offered an alternative highly fluorescent NIR-II material and demonstrated a promising approach for real-time pharmaceutical evaluation of nanomedicine in vivo.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05885?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05885</a>.Additional experimental methods, the synthetic route to DTTB, NMR spectra of DTTB, HRMS spectra of DTTB, UV–vis–NIR spectra and emission spectra of DTTB, TEM image of and NMs, PA imaging stability test of ICG and solution, ex vivo NIR-II fluorescence imaging of major organs, photothermal properties tests of , photothermal ablation efficiency assessment of in vitro, and hemolysis analysis of (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_001.pdf">PDF</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_002.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_003.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_004.avi">AVI</a>)This article has not yet been cited by other publications.

NIR-II Fluorescence Imaging Reveals Bone Marrow Retention of Small Polymer Nanoparticles

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Imaging: Conjugated Polymer Amplified Far‐Red/Near‐Infrared Fluorescence from Nanoparticles with Aggregation‐Induced Emission Characteristics for Targeted in Vivo Imaging (adv. Healthcare Mater. 3/2013)

Excretable Lanthanide Nanoparticle For Biomedical Imaging And Surgical Navigation In The Second Near-Infrared Window

Nanoparticles Passive Targeting Allows Optical Imaging of Bone Diseases

In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation

Pharmacokinetics and Biodistribution of Near-Infrared Fluorescence Polymeric Nanoparticles

Biocompatible Near-Infrared Fluorescent Nanoparticles for Macro and Microscopic in Vivo Functional Bioimaging.

Gold Nanoclusters for NIR‐II Fluorescence Imaging of Bones

An NIR-II Probe with High PSMA Affinity Demonstrates an Unexpected Excellent Bone Imaging Ability

Biological Imaging Using Nanoparticles of Small Organic Molecules with Fluorescence Emission at Wavelengths Longer Than 1000 Nm.

An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging

Bone disease imaging through the near-infrared-II window

Genetically Modified Ferritin Nanoparticles with Bone-Targeting Peptides for Bone Imaging

A Near-Infrared-II Polymer with Tandem Fluorophores Demonstrates Superior Biodegradability for Simultaneous Drug Tracking and Treatment Efficacy Feedback

NIR-II Ratiometric Lanthanide-Dye Hybrid Nanoprobes Doped Bioscaffolds for In Situ Bone Repair Monitoring

Encapsulation-Dependent Enhanced Emission of Near-Infrared Nanoparticles Using in Vivo Three-Photon Fluorescence Imaging

X-ray-activated persistent luminescence nanomaterials for NIR-II imaging

Multilayered Semiconducting Polymer Nanoparticles with Enhanced NIR Fluorescence for Molecular Imaging in Cells, Zebrafish and Mice.

Nano-confinement-driven enhanced magnetic relaxivity of SPIONs for targeted tumor bioimaging

From bone to nanoparticles: development of a novel generation of bone derived nanoparticles for image guided orthopedic regeneration